BioCentury | Jul 14, 2003
Company News

Bac BarCodes management update

...Houston, Texas Business: Microfluidics, Supply/Service Hired: David McWilliams as president and CEO, formerly CEO of Signase Inc. WIR...
BioCentury | Sep 9, 2002
Emerging Company Profile

Corporate Profile

Signase Inc. Houston, Texas Technology: Assays and small molecule compound libraries related to Src family Disease focus: Cancer Clinical status: Preclinical Founded: 1997 by Victor Levin and Raymond Budde Corporate partners: Tripos Inc. University collaborators:...
BioCentury | Sep 9, 2002
Emerging Company Profile

Signase: Src revival

...as the target that will create the next blockbuster anti-cancer drug. Though focused on cancer, Signase Inc....
...of Src inhibitors to treat cancer has yet to be productive. One reason, according to Signase...
...Src and a lack of scalable assays to quantify their activity. To circumvent these problems, Signase...
BioCentury | Jun 24, 2002
Company News

Signase management update

Signase Inc. , Houston, Texas Business: Chemistry, Musculoskeletal, Cancer Hired: David McWilliams as CEO and a director, formerly president, CEO and a director of Texas Biotechnology Corp. WIR Staff...
BioCentury | May 6, 2002
Company News

Signase, Tripos deal

...The companies extended a deal to identify compounds that inhibit Src kinases. The deal combines Signase's...
...receive a service payment and is eligible for royalties, made an equity investment in Signase. Signase Inc....
BioCentury | Jan 2, 2001
Company News

Signase board of directors update

...Financing, B21) Signase Inc. , Houston, Texas Business: Cancer Appointed: Eric Linsley, chief investment officer at A.M...
Items per page:
1 - 6 of 6
BioCentury | Jul 14, 2003
Company News

Bac BarCodes management update

...Houston, Texas Business: Microfluidics, Supply/Service Hired: David McWilliams as president and CEO, formerly CEO of Signase Inc. WIR...
BioCentury | Sep 9, 2002
Emerging Company Profile

Corporate Profile

Signase Inc. Houston, Texas Technology: Assays and small molecule compound libraries related to Src family Disease focus: Cancer Clinical status: Preclinical Founded: 1997 by Victor Levin and Raymond Budde Corporate partners: Tripos Inc. University collaborators:...
BioCentury | Sep 9, 2002
Emerging Company Profile

Signase: Src revival

...as the target that will create the next blockbuster anti-cancer drug. Though focused on cancer, Signase Inc....
...of Src inhibitors to treat cancer has yet to be productive. One reason, according to Signase...
...Src and a lack of scalable assays to quantify their activity. To circumvent these problems, Signase...
BioCentury | Jun 24, 2002
Company News

Signase management update

Signase Inc. , Houston, Texas Business: Chemistry, Musculoskeletal, Cancer Hired: David McWilliams as CEO and a director, formerly president, CEO and a director of Texas Biotechnology Corp. WIR Staff...
BioCentury | May 6, 2002
Company News

Signase, Tripos deal

...The companies extended a deal to identify compounds that inhibit Src kinases. The deal combines Signase's...
...receive a service payment and is eligible for royalties, made an equity investment in Signase. Signase Inc....
BioCentury | Jan 2, 2001
Company News

Signase board of directors update

...Financing, B21) Signase Inc. , Houston, Texas Business: Cancer Appointed: Eric Linsley, chief investment officer at A.M...
Items per page:
1 - 6 of 6